A DRUG-RESISTANT ASSAY CAN BETTER DIRECT THE NEED FOR ADALIMUMAB DOSE-ESCALATION AFTER INDUCTION THERAPY IN ANTI-TNF NAÏVE PATIENTS WITH CROHN’S DISEASE

Gitte Moors  1     Bram Verstockt  1     Sumin Bian  2     Sophie Tops  3     Vera Ballet     Gert Van Assche     Severine Vermeire     Ann Gils     Marc Ferrante    
1 University Hospitals Leuven,Department of Gastroenterology and Hepatology,Leuven,Belgium
2 KU Leuven,Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences,Leuven,Belgium
3 KU Leuven,Laboratory

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing